(Q42083306)

16 October 2017

title

Use of tissue plasminogen activator in the emergency department for acute myocardial infarction (English)

1 reference

16 October 2017

4

Topol EJ

1 reference

16 October 2017

Walsh DG

1

1 reference

16 October 2017

Kaplan LR

series ordinal

2

1 reference

16 October 2017

Burney RE

series ordinal

3

1 reference

16 October 2017

O'Neill WW

series ordinal

5

1 reference

16 October 2017

language of work or name

English

0 references

publication date

1 March 1987

1 reference

Annals of Emergency Medicine

16 October 2017

published in

1 reference

16 October 2017

volume

16

1 reference

16 October 2017

issue

3

1 reference

16 October 2017

page(s)

243-247

1 reference

Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli

16 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980166-X

7 January 2021

Human tissue-type plasminogen activator: from the laboratory to the bedside

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980166-X

7 January 2021

Analysis of coagulation and fibrinolysis during intravenous infusion of recombinant human tissue-type plasminogen activator in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980166-X

7 January 2021

Coronary thrombolysis with tissue-type plasminogen activator in patients with evolving myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980166-X

7 January 2021

Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980166-X

7 January 2021

Randomised trial of intravenous recombinant tissue-type plasminogen activator versus intravenous streptokinase in acute myocardial infarction. Report from the European Cooperative Study Group for Recombinant Tissue-type Plasminogen Activator

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980166-X

7 January 2021

Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980166-X

7 January 2021

Percutaneous transluminal coronary angioplasty: Application for acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980166-X

7 January 2021

Applicability of percutaneous transluminal coronary angioplasty to patients with recombinant tissue plasminogen activator mediated thrombolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980166-X

7 January 2021

Percutaneous transluminal coronary angioplasty, alone or in combination with streptokinase therapy, during acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980166-X

7 January 2021

Emergency aeromedical transport of patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2887%2980166-X

7 January 2021

10.1016/S0196-0644(87)80166-X

Identifiers

DOI

1 reference

16 October 2017

1 reference